K Jessica Norberg1, Salvatore Nania1, Xuan Li1, Hui Gao2, Peter Szatmary3, Ralf Segersvärd4, Stephan Haas4, Annika Wagman1, Urban Arnelo4, Robert Sutton3, Rainer L Heuchel1, J Matthias Löhr5. 1. Pancreas Cancer Research Lab, Dept. of Clinical Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden. 2. Dept. of Biosciences and Nutrition (BioNut), Karolinska Institutet, Stockholm, Sweden. 3. Liverpool Pancreatitis Research Group, Institute of Translational Medicine, University of Liverpool, Liverpool, England, UK. 4. Centre for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden. 5. Pancreas Cancer Research Lab, Dept. of Clinical Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden; Centre for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden. Electronic address: matthias.lohr@ki.se.
Abstract
BACKGROUND: To date, there still is a lack of specific acute pancreatitis markers and specifically an early marker that can reliably predict disease severity. The inflammatory response in acute pancreatitis is mediated in part through oxidative stress and calcineurin-NFAT (Nuclear Factor of Activated T-cells) signaling, which is inducing its own negative regulator, regulator of calcineurin 1 (RCAN1). Caerulein induction is a commonly used in vivo model of experimental acute pancreatitis. Caerulein induces CN-NFAT signaling, reactive oxygen species and inflammation. METHODS: To screen for potential markers of acute pancreatitis, we used the caerulein model of experimental acute pancreatitis (AP) in C57Bl/6 J mice. Pancreata from treated and control mice were used for expression profiling. Promising gene candidates were validated in cell culture experiments using primary murine acinar cells and rat AR42J cells. These candidates were then further tested for their usefulness as biomarkers in mouse and human plasma. RESULTS: We identified a number of novel genes, including Regulator of calcineurin 1 (Rcan1) and Sestrin 2 (Sesn2) and demonstrated that they are induced by oxidative stress, by stimulation with H2O2 and by inhibiting caerulein stimulated expression with the antioxidant N-acetylcysteine. We found Rcan1 protein to be significantly elevated in AP-induced mouse plasma as well as in plasma from AP patients. CONCLUSION: We demonstrated that Rcan1 is regulated by oxidative stress and identified RCAN1 as a potential diagnostic marker of AP.
BACKGROUND: To date, there still is a lack of specific acute pancreatitis markers and specifically an early marker that can reliably predict disease severity. The inflammatory response in acute pancreatitis is mediated in part through oxidative stress and calcineurin-NFAT (Nuclear Factor of Activated T-cells) signaling, which is inducing its own negative regulator, regulator of calcineurin 1 (RCAN1). Caerulein induction is a commonly used in vivo model of experimental acute pancreatitis. Caerulein induces CN-NFAT signaling, reactive oxygen species and inflammation. METHODS: To screen for potential markers of acute pancreatitis, we used the caerulein model of experimental acute pancreatitis (AP) in C57Bl/6 J mice. Pancreata from treated and control mice were used for expression profiling. Promising gene candidates were validated in cell culture experiments using primary murine acinar cells and rat AR42J cells. These candidates were then further tested for their usefulness as biomarkers in mouse and human plasma. RESULTS: We identified a number of novel genes, including Regulator of calcineurin 1 (Rcan1) and Sestrin 2 (Sesn2) and demonstrated that they are induced by oxidative stress, by stimulation with H2O2 and by inhibiting caerulein stimulated expression with the antioxidant N-acetylcysteine. We found Rcan1 protein to be significantly elevated in AP-induced mouse plasma as well as in plasma from AP patients. CONCLUSION: We demonstrated that Rcan1 is regulated by oxidative stress and identified RCAN1 as a potential diagnostic marker of AP.
Authors: Pedro Silva-Vaz; Ana Margarida Abrantes; Miguel Castelo-Branco; António Gouveia; Maria Filomena Botelho; José Guilherme Tralhão Journal: Int J Mol Sci Date: 2019-06-07 Impact factor: 5.923
Authors: Seung-Hyun Ro; Julianne Fay; Cesar I Cyuzuzo; Yura Jang; Naeun Lee; Hyun-Seob Song; Edward N Harris Journal: Front Cell Dev Biol Date: 2020-12-03
Authors: Vlad Pădureanu; Dan Nicolae Florescu; Rodica Pădureanu; Alice Elena Ghenea; Dan Ionuț Gheonea; Carmen Nicoleta Oancea Journal: Exp Ther Med Date: 2022-01-05 Impact factor: 2.447
Authors: Julie K Bray; Ola A Elgamal; Jinmai Jiang; Lais S Wright; Dhruvitkumar S Sutaria; Mohamed Badawi; Madeline G Borcyk; Xiuli Liu; Kristianna M Fredenburg; Martha L Campbell-Thompson; Thomas D Schmittgen Journal: Cell Death Dis Date: 2020-02-20 Impact factor: 8.469
Authors: Jeetindra R A Balak; Juri Juksar; Françoise Carlotti; Antonio Lo Nigro; Eelco J P de Koning Journal: Curr Diab Rep Date: 2019-12-11 Impact factor: 4.810